GC Therapeutics (GCTx), a pioneering biotechnology company advancing the next generation of cell-based medicines through its TFome™ (Transcription-Factor-ome) induced pluripotent stem cell (iPSC) ...
There is a high unmet need for accessible, affordable, and high-quality fertility care, as approximately 1 in 6 people are affected by infertility worldwide. While meiotic failure is a major cause of ...
Pluristyx, a leading provider of clinical-grade induced pluripotent stem cell (iPSC) solutions, and Qkine, a pioneer in the manufacture of high-purity, animal-free growth factors and cytokines, today ...
Spurred by the discoveries of human pluripotent stem cell culture by James Thomson in the 1990s and the induction of pluripotency from adult cells by Shinya Yamanaka in the 2000s, therapeutics derived ...
For stem cells to differentiate into the appropriate cell-type, transcription factors (TFs) must be tailored to highly specific expression patterns of lineage-specific genes. Abnormalities in the ...
The olfactory system is essential for most animals: it supports postnatal survival, detects environmental hazards and mediates emotional, social and nutritional behaviors.
Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of ...
New analysis suite helps cell engineering teams benchmark target identity, detect off-target states, and prioritize protocol ...
Amsbio has expanded its range of iPSC Differentiation Kits, offering faster and more flexible generation of specific neural ...
Refined stem cell protocol has delivered high-purity, glucose-responsive insulin-producing cells that restore blood sugar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results